Poster Presentations in secondary spongious zone and diaphyseal cortical bone and slightly in primary spongious area, and iii) bone microarchitecture showed higher values of BV/TV, Tb.th, Tb.N and lower value of Tb.Spin treated rats. Finally, we demonstrated that the overproduction of RANKL and IL-17 in sera of arthritic animals was prevented by pioglitazone treatment.
and mature osteoclasts on bone. Finally, mature osteoclasts were seeded on calcified cartilage from bovine knee joints, human trabecular bone from vertebrae and human cortical bone from femurs in the presence or absence of resorption inhibitors. Results: Osteoclastogenesis was clearly seen when measuring TRACP, CTX-I and calcium release, with TRACP release initiated on day 5 of culture and CTX-I and calcium release on day 7. All markers were increased more than 500% (P<0.01), compared to initial values. TRACP staining confirmed the presence of large multinucleated TRACP positive cells. For the mature human osteoclasts intense bone resorption was observed within 24 hours after seeding on bovine bone slices, and bone resorption was attenuated by more than 70% in the presence of the resorption inhibitors (P<0.01). Immunocytochemistry for CTR and TRACP clearly demonstrated the presence of mature osteoclasts. Interestingly human osteoclasts also resorbed the calcified cartilage, the human trabecular and cortical bones, although differences in the level of resorption were observed, suggesting an induction of distinct osteoclast phenotypes that is dependent on the extracellular matrix at which they are activated.
Conclusions:
We have demonstrated that CD14+ monocytes isolated from human peripheral blood are a highly useful source of osteoclasts, which are characterized by expression of the CTR, TRACP and bone resorption, all which are hallmarks of osteoclast function. We used this high quality osteoclast preparation to demonstrate that osteoclasts resorb calcified cartilage, and since this process is involved in the pathogenesis of OA this system can be used for characterizing osteoclast related effects on joint turnover.
DIABETIC MICE HAD A DECREASED EXPRESSION OF DENDRITIC CELL-SPECIFIC TRANSMEMBRANE PROTEIN
T. Kasahara 1 , S. Imai 1 , H. Kojima 2 , H. Kimura 2 , Y. Matsusue 1 1 Orthopedic Surgery, Shiga Univ. of Med. Sci., Otsu Shiga, Japan; 2 Molecular Genetics Med., Shiga Univ. of Med. Sci., Otsu Shiga, Japan Purpose: We have reported that the impairment of osteoclast fusion had important roles for the delayed fracture healing in streptozotocin (STZ)-induced diabetic mice. In this study, we further investigated the mechanism of the malfunction of diabetic osteoclasts using genetic analysis in vivo and cell culture in vitro. Methods: The C57BL/6 mice were irradiated (9 Gy) and injected with 4 × 10 6 bone marrow cells isolated from C57BL/6-EGFP mice. The diabetes was induced by intravenous administration of STZ (150 mg·kg -1 in mice). The control was injected with sodium citrate buffer. At 6 weeks after transfer, bone marrow cells were isolated from both the STZ and control groups, and then cultured in the 96well dish with the cortical bone plate. The cortical bone plates were extraction skull bones of wild type C57BL/6, and those were fixed and dehydrated with 100% ethanol. The cell culture was performed in DMEM supplemented with 10% fetal bovine serum under 5% CO 2 and 95% air at 37°C, and the floating cell was removed after 2 h incubation. On day 3, 5, and 7, the cortical bone plates were examined to analyze the formation of the resorption pits by a scanning electron microscope. The standardized closed fracture models were created in both the control and STZ group. At 2 weeks after the fracture, the frozen sections of the fracture site were created. The osteoclasts at callus area were captured by laser capture microdissection (LCM). We extracted RNA and synthesized cDNA by using commercial kit. RT-PCR was performed to evaluate the mRNA expressions of MMP9, Catepsin-K, Receptor activator of NF-kappaB (RANK), dendritic cell-specific transmembrane protein (DC-STAMP), and GAPDH.
Results: The resorption pits made by osteoclasts were well demonstrated on the cortical bone plates. The area of the resorption pits became larger sequentially on day 3, 5, and 7 in osteoclast-cell culture. In the STZ group, the resorption-pit area was significantly decreased compared with that in control group. The expression levels of MMP9, Catepsin-K, and RANK showed no difference in between control and STZ group. On the other hand, expression levels of DC-STAMP were significantly decreased in STZ group. Conclusions: In the last meeting, we reported that the osteoclast fusion was impaired, the cartilage resorption was decreased, and the endocondral ossification was delayed in the STZ-induced diabetic mice. In this study, we found that the impaired bone resorption in STZ might be produced by a decreased expression of DC-STAMP in osteoclasts. Since DC-STAMP has a central role for the formation of multinuclear osteoclasts, our result indicates that the up-regulation of DC-STAMP may be useful to prevent osteopenia in diabetes mellitus.
COMPRESSION INDUCES THE EXPRESSION OF A SCLEROTIC PHENOTYPE IN HUMAN SUBCHONDRAL OSTEOBLASTS
C. Sanchez 1 , O. Gabay 2 , L. Pesesse 1 , P. Msika 3 , C. Baudouin 3 , Y.E. Henrotin 1 1 Univ. of Liège, Liège, Belgium; 2 NIH, Bethesda, MD; 3 Laboratoires ExpanSci., Epernon, France Purpose: Recent data showed that subchondral bone plays an important role in osteoarthritis (OA). Metabolic and morphologic modifications in this tissue contribute to the degradation of the overlaying cartilage. It was suggested that abnormal mechanical pressure applied to the articulation was responsible to these changes. Here, we evaluated the effects of compression on osteoblasts from subchondral bone. Methods: Osteoblasts were isolated from sclerotic (SC) or nonsclerotic (NSC) areas of human OA subchondral bone. After 28 days, osteoblasts were surrounded by a newly synthesized matrix and formed a strong membrane. This osteoblasts-containing membrane was then placed onto a Biopress Flexercell plate and submitted to compression (1.67 MPa) for 4 hours at the frequency of 1 Hz. The expression of IL-6, IL-8, COX-2, VEGF, IGF-1, OPG and RANKL was evaluated by RT-PCR. IL-6, IL-8 and PGE2 were quantified by ELISA. Results: Basal IL-6, VEGF, COX-2, IGF-1 and RANKL mRNA levels were significantly increased in SC osteoblasts as compared to NSC. By contrast, SC osteoblasts expressed less OPG than those from NSC areas. Compressions induced the expression of genes coding for IL-6, IL-8, COX-2, IGF-1, VEGF and RANKL but decreased the expression of OPG in NSC osteoblasts (p<0.01). IL-6, IL-8 and PGE2 productions were also stimulated by compressions. Interestingly, compressed NSC osteoblasts expressed similar levels of these genes than SC osteoblasts, suggesting that mechanical strains could be responsible for SC phenotype. Conclusions: These results indicate that in response to compression NSC osteoblasts expressed a phenotype similar to that of SC osteoblasts. Moreover, SC osteoblasts are less sensitive to mechanical stimuli than NSC osteoblasts. These results clarify the role of compression in the pathogenesis of subchondral bone sclerosis and allow new perspectives of research in this field.
